Group items tagged

Analysis by IQVIA revealed that over the past four years, from May 2020 to May 2024, the average number of prescriptions processed by pharmacies has risen by 8 million per month. However, this is happening against the backdrop of a declining number of pharmacies. During these four years, nearly 900 pharmacies have closed in England, with almost 500 of those closures occurring in the last 12 months. Carol Alexandre, vice president at IQVIA, presented the data at the recent SIGMA UK Community Pharmacy Conference 2024, where she shared insights into the dynamics of the UK market, the pharmacy sector, and the Pharmacy First initiative. As of August 2024, there were just 10,059 community pharmacies (excluding distance-selling pharmacies) in England, 1,589 less than in March 2015, when the number stood at 11,647 (source: NHS BSA). There has been a significant shift in the distribution of pharmacy ownership, with independents (single pharmacies and chains with 1-5 stores) and regional chains (pharmacy chains with 6-200 stores) growing at the expense of managed chains.

This year has been another turbulent year for the UK pharmacy sector. The sector continues to undergo significant transformations, driven by evolving healthcare needs, regulatory shifts, and economic pressures. For pharmacy owners, staying abreast of these trends is crucial to navigating the challenges and seizing opportunities. IQVIA, a leading global provider of clinical research services, commercial insights and healthcare intelligence, delves into the key issues, challenges, and developments shaping the sector, drawing insights from the latest industry data and reports, supported with data released by NHS England (NHSE). The community pharmacy landscape remains unsettled, with disruptive market dynamics at play. The decline in the number of pharmacies, particularly within the Managed Chains channel, underscores the volatility of the market. The number of active pharmacy contractors in England has dropped significantly, with more closures than openings each month, exacerbated by the exit of Lloyds Pharmacy from the UK market which completed at the end of 2023. In the year ending June 2024, there was a net closure of 440 sites within NHSE which equates to a 4% decline in available pharmacies1. The increase in closures from June 2023 was driven by the closures of Lloyds in Sainsburys and the ongoing divestment of the Boots estate.

Raylane Pharmacy Group has expanded its portfolio by acquiring Evans Pharmacy in Worcestershire. With this new addition, the independent community pharmacy chain has increased its total number of branches to 10. Located in the centre of Malvern Link in Worcestershire, Evans Pharmacy dispenses approximately 10,000 items per month. The acquisition follows the retirement of the previous owner, Philip Hawkes, who had managed the business for over a decade. The sale was facilitated by Christie and Co through a confidential process, and the transaction price remains undisclosed. Commenting on the deal, Carl Steer, director-pharmacy at Christie and Co, said: "The sale represents a perfect addition to an already successful group for Raylane Ltd. "The instruction proved popular, and the completion represents another sale for Christie and Co in a record year for pharmacy sales."

Well Pharmacy, the UK's largest independent pharmacy chain, recently announced the opening of a new store inside WHSmith's flagship airside location at Birmingham Airport. This expansion is part of Well Pharmacy's ongoing collaboration with WHSmith, the global travel retailer. Situated within the departure lounge of Birmingham Airport, the biggest and busiest airport in the Midlands and the seventh largest in the UK, the new pharmacy will offer travelers a wide range of pharmacy products and expert healthcare services. The new pharmacy complements WHSmith's extensive selection of health and beauty items, travel essentials, food-to-go, and tech products. Andrew Caplan, chief retail officer at Well Pharmacy, expressed enthusiasm about the continued partnership. "Well Pharmacy are delighted to continue to work in partnership with WHSmith in providing a one stop shop for all travellers' needs," he stated.

Pharmacy hub and spoke providers gathered at Westminster on Tuesday (November 19) to highlight to MPs the urgent need to implement Model One of Hub and Spoke legislation. This proposed model, aimed at making hub and spoke dispensing accessible to all pharmacies, was initially scheduled for rollout in January 2025, but has been delayed. Representatives from Centred Solutions, HubRx, and PillTime engaged with over 30 MPs at the event, which was organised with the support of former pharmacist and Labour MP Sadik Al-Hassan. They highlighted the significant benefits of hub and spoke for community pharmacies and stressed the need to extend its use across different legal entities. Sadik Al-Hassan, MP for North Somerset and officer for the Pharmacy APPG, expressed his support, saying, "Community pharmacies are a vital lifeline for our high streets and independents have always been at a disadvantage versus larger chains who can employ economies of scale. "Model One of the proposed legislation would allow the benefits of big pharmacies for smaller ones to help them focus on the service provision our NHS needs during this difficult financial time."